North and Central Texas Clinical and Translational Science Initiative (TL1)
德克萨斯州北部和中部临床和转化科学计划 (TL1)
基本信息
- 批准号:8096647
- 负责人:
- 金额:$ 6.24万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-09-15 至 2012-07-23
- 项目状态:已结题
- 来源:
- 关键词:AddressAdvanced DevelopmentAwardAwarenessBasic ScienceClinicalClinical ResearchClinical SciencesCommunitiesDisciplineDoctor of PhilosophyDoctor&aposs DegreeEducationEducational CurriculumFacultyFundingInstitutionKnowledgeMaster&aposs DegreeMentored Clinical Scientist Development ProgramMentorsMinorityPathway interactionsPerformancePostdoctoral FellowQualifyingResearchResearch PersonnelResearch TrainingStudentsTexasTrainingTraining ProgramsTraining and EducationTranslational ResearchUnderrepresented MinorityUnited States National Institutes of HealthWomanbasecareercareer developmentexperienceimprovedinnovationinterestminority traineenoveloutreach programpostdoctoral investigatorpre-doctoralprogramsrole modelskillssymposium
项目摘要
The Research Education. Training and Career Development Program will enhance the knowledge of and improve the skills required for the performance of high-quality innovative clinical and translational research, and thereby, advance the development of trainees planning a career in or interested in contributing meaningfully to clinical or translational research. We will provide outstanding short-, intermediate-, and long-term programs for predoctoral, postdoctoral, and nondoctoral trainees across all disciplines at all NCTCTSI participating institutions. In particular, we will enhance the participation of women and minority trainees.
We proposed this approach to the NIH last year during the first cycle of competition for CTSA awards. Our proposal received very favorable reviews; with an overall score of 177, we just missed the pay line for funding. These positive reviews enforced our faith in the direction we were taking. During last year, we enthusiastically moved forward with our efforts and have gained additional experience. This experience leads us now to revise our original proposal. This revised section builds substantially on our original plan; fully addresses the concerns of the reviewers; and demonstrates our commitment to contribute novel and effective approaches to the NIH's effort to identify and implement best practices.
研究教育。培训和职业发展计划将提高知识和提高高质量创新临床和转化研究所需的技能,从而促进计划职业生涯或有兴趣为临床或转化研究做出有意义贡献的学员的发展。我们将为所有NCTCTSI参与机构的所有学科的博士前,博士后和非博士学员提供优秀的短期,中期和长期课程。特别是,我们将加强妇女和少数民族受训人员的参与。
去年,我们在CTSA奖项的第一轮竞争中向NIH提出了这种方法。我们的提案得到了非常好的评价;总分为177分,我们刚刚错过了资金的支付线。这些积极的评论加强了我们对我们所走方向的信心。在过去一年中,我们积极地作出努力,并取得了更多的经验。这一经验使我们现在要修改我们原来的建议。这一修订后的部分在很大程度上建立在我们原来的计划上;充分解决了评审者的关切;并表明我们致力于为NIH确定和实施最佳实践的努力贡献新颖有效的方法。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Sedentary behaviors and obesity in a low-income, ethnic-minority population.
- DOI:10.1123/jpah.10.1.134
- 发表时间:2013
- 期刊:
- 影响因子:3.1
- 作者:Kerem Shuval;Tammy Leonard;J. Murdoch;M. Caughy;H. Kohl;C. Skinner
- 通讯作者:Kerem Shuval;Tammy Leonard;J. Murdoch;M. Caughy;H. Kohl;C. Skinner
Effect of PF-02341066 and radiation on non-small cell lung cancer cells.
- DOI:10.3892/or.2012.2198
- 发表时间:2013-03
- 期刊:
- 影响因子:4.2
- 作者:Tumati V;Kumar S;Yu L;Chen B;Choy H;Saha D
- 通讯作者:Saha D
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROBERT Daniel TOTO其他文献
ROBERT Daniel TOTO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROBERT Daniel TOTO', 18)}}的其他基金
Kidney Precision Medicine Project - Patient Engagement
肾脏精准医学项目 - 患者参与
- 批准号:
10701778 - 财政年份:2022
- 资助金额:
$ 6.24万 - 项目类别:
Kidney Precision Medicine Project - Patient Engagement
肾脏精准医学项目 - 患者参与
- 批准号:
10492871 - 财政年份:2022
- 资助金额:
$ 6.24万 - 项目类别:
UT Southwestern Center for Translational Medicine
德州大学西南转化医学中心
- 批准号:
10412141 - 财政年份:2021
- 资助金额:
$ 6.24万 - 项目类别:
UT Southwestern Center for Translational Medicine
德州大学西南转化医学中心
- 批准号:
10349035 - 财政年份:2021
- 资助金额:
$ 6.24万 - 项目类别:
UT Southwestern Center for Translational Medicine
德州大学西南转化医学中心
- 批准号:
10614619 - 财政年份:2021
- 资助金额:
$ 6.24万 - 项目类别:
Association of baseline and time-varying serum magnesium levels with cardiovascular disease events in SPRINT participants with and without chronic kidney disease
患有或不患有慢性肾病的 SPRINT 参与者中基线和随时间变化的血清镁水平与心血管疾病事件的关联
- 批准号:
9815059 - 财政年份:2019
- 资助金额:
$ 6.24万 - 项目类别:
Chronic Kidney Disease Precision Medicine Project
慢性肾脏病精准医疗项目
- 批准号:
10223908 - 财政年份:2017
- 资助金额:
$ 6.24万 - 项目类别:
UT Southwestern Center for Translational Medicine (UL1/KL2/TL1
UT 西南转化医学中心 (UL1/KL2/TL1
- 批准号:
8721031 - 财政年份:2013
- 资助金额:
$ 6.24万 - 项目类别:
UT Southwestern Center for Translational Medicine (UL1/KL2/TL1)
UT 西南转化医学中心 (UL1/KL2/TL1)
- 批准号:
9065628 - 财政年份:2013
- 资助金额:
$ 6.24万 - 项目类别:
相似海外基金
ADVANCED DEVELOPMENT OF LQ A LIPOSOME-BASED SAPONIN-CONTAINING ADJUVANT FOR USE IN PANSARBECOVIRUS VACCINES
用于 Pansarbecovirus 疫苗的 LQ A 脂质体含皂苷佐剂的先进开发
- 批准号:
10935820 - 财政年份:2023
- 资助金额:
$ 6.24万 - 项目类别:
ADVANCED DEVELOPMENT OF BBT-059 AS A RADIATION MEDICAL COUNTERMEASURE FOR DOSING UP TO 48H POST EXPOSURE"
BBT-059 的先进开发,作为辐射医学对策,可在暴露后 48 小时内进行给药”
- 批准号:
10932514 - 财政年份:2023
- 资助金额:
$ 6.24万 - 项目类别:
Advanced Development of a Combined Shigella-ETEC Vaccine
志贺氏菌-ETEC 联合疫苗的先进开发
- 批准号:
10704845 - 财政年份:2023
- 资助金额:
$ 6.24万 - 项目类别:
Advanced development of composite gene delivery and CAR engineering systems
复合基因递送和CAR工程系统的先进开发
- 批准号:
10709085 - 财政年份:2023
- 资助金额:
$ 6.24万 - 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
- 批准号:
10409385 - 财政年份:2022
- 资助金额:
$ 6.24万 - 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
- 批准号:
10710595 - 财政年份:2022
- 资助金额:
$ 6.24万 - 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
- 批准号:
10630975 - 财政年份:2022
- 资助金额:
$ 6.24万 - 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE CANDIDATE FOR STAPHYLOCOCCUS AUREUS INFECTION
金黄色葡萄球菌感染候选疫苗的高级开发
- 批准号:
10710588 - 财政年份:2022
- 资助金额:
$ 6.24万 - 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
- 批准号:
10788051 - 财政年份:2022
- 资助金额:
$ 6.24万 - 项目类别: